National Institute on Drug Abuse (NIDA) Funding Opportunities
The National Institute on Drug Abuse (NIDA) would like to announce some funding opportunities available for small businesses:
- Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants Use Disorders (OUD/StUD)
- R41/42 STTR (RFA-DA-24-038)
- R43/44 SBIR (RFA-DA-23-021)
- Due dates: February 14, 2024; August 13, 2024; February 14, 2025
- Award Budget: Total funding support may not exceed $400,000 for Phase I awards and $3,000,000 for Phase II awards.
- Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders
- R41/42 STTR (RFA-DA-25-053)
- R43/44 SBIR (RFA-DA-25-054)
- Due date: July 25, 2024
- Award Budget: Total funding support may not exceed $400,000 for Phase I awards and $3,000,000 for Phase II awards.
About NIDA:
NIDA’s mission is to advance science on drug use and addiction and to apply that knowledge to improve individual and public health. This involves:
-
- Strategically supporting and conducting basic and clinical research on drug use (including nicotine), its consequences, and the underlying neurobiological, behavioral, and social mechanisms involved.
- Ensuring the effective translation, implementation, and dissemination of scientific research findings to improve the prevention and treatment of substance use disorders and enhance public awareness of addiction as a brain disorder.
For more information about NIDA, visit their website.